SGO1 and hepatocellular carcinoma: Liu et al. concluded that SGO1 inhibits the growth of lung cancer cells and promotes apoptosis.28 Fei et al. proved that SGO1 is highly expressed in HCC tissues, is a biomarker with poor prognosis, may be related to immune cell infiltration in HCC, and may enhance the proliferation, invasion, and migration of HCC cells.29 Thus, SGO1 may offer a new therapeutic avenue for cancer treatment.